Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease

Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.

29 Apr 2010

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

Using a new mouse model of Alzheimer's disease, researchers at Mount Sinai School of Medicine have found that Alzheimer's pathology originates in Amyloid-Beta (Abeta) oligomers in the brain, rather than the amyloid plaques previously thought by many researchers to cause the disease.

28 Apr 2010

FIESTY acronym to improve cognitive function, reduce chances of developing dementia

As researchers learn more about how we age, they're finding that genetics are only half of the story when it comes to developing Alzheimer's disease.

28 Apr 2010

A first step in the long road to health reform

Australia provides good health care to the majority of its citizens most of the time and compares well with like countries. The capacity for illness to destroy families financially, seen in the US and in many less economically advanced countries where governments make small or no contributions to the cost of health care, is much diminished by Medicare, public hospitals and subsidised pharmaceuticals.

27 Apr 2010

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has acquired the U.S. marketing rights to LODOSYN (carbidopa) tablets from Bristol-Myers Squibb Company.

26 Apr 2010

Intellect Neurosciences completes restructuring of balance sheet

Intellect Neurosciences, Inc., a biopharmaceutical company focused on development of disease-modifying therapeutic agents for Alzheimer's disease, announced today it has completed a restructuring of its balance sheet. The result is the extinguishment of approximately $24 million of aggregate face amount plus accrued interest of debt and preferred stock through the issuance of common stock.

26 Apr 2010

Elderlink offers personalized referral lists for senior citizens and their families

Elderlink, Inc., a free senior care referral service serving California since 1994, is offering senior citizens and their families the ability to find the care they need via personalized referral lists based upon their individual needs.

26 Apr 2010

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

A team of collaborating researchers from the Swedish universities of Umeå, Stockholm, and Linköping is now publishing data showing that long telomeres in non-demented adults and seniors can be associated with poorer memory.

26 Apr 2010

Heritage Club Mountain View to host intense competition and educational event

A dynamic culinary competition among area professional senior living chefs highlights healthy cooking, wellness and quality of life for older adults. During the culinary cook-off, the culinary professionals from Brookdale Senior Living, industry-leading owners and operators of senior living communities, will entertain and showcase their culinary talents to compete for the chance to win the "Ultimate Chef America" title.

26 Apr 2010

High nitrate concentrations in drinking water are a potential hazard to human health

A new study exploring the growing worldwide problem of nitrogen pollution from soils to the sea shows that global ratios of nitrogen and carbon in the environment are inexorably linked, a finding that may lead to new strategies to help mitigate regional problems ranging from contaminated waterways to human health.

26 Apr 2010

World’s largest study on the safety of using mobile phones

Health experts have been saying that mobile phones are bad for us for a long time. Now they are getting set to prove it beyond any doubt. Researchers in London recently launched the world’s largest study on the safety of using mobile phones. A quarter of a million mobile phone users will be tracked through their medical records for more than 20 years. This is the largest study in the world on the health effects of using mobile phones and is being called Cosmos.

25 Apr 2010

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.

24 Apr 2010

Research into Planarian worm 'Smed-prep' gene may pave way for regeneration of human organs

Scientists at The University of Nottingham have discovered the gene that enables an extraordinary worm to regenerate its own body parts after amputation — including a whole head and brain.

23 Apr 2010

People who provide care to family members with dementia experience stress, depression: Researchers

Family members who provide care to relatives with dementia, but do not have formal training, frequently experience overwhelming stress that sometimes leads to breakdowns or depression, according to Penn State and Benjamin Rose Institute researchers. Interventions to alleviate this stress are not always effective, leaving caregivers isolated to deal with their stresses.

23 Apr 2010

Alzheimer's Association's hosts conference to educate and support NH people with the disease

Alzheimer's disease can be devastating to families who become caregivers. Anyone seeking more information about Alzheimer's is invited to attend the Alzheimer's Association's "Care to Cure: the latest in research and care giving" conference on Saturday, May 22 in Concord.

23 Apr 2010

Study describes relationship between gene expression and intelligence in WS patients

Although genetics is the most significant known determinant of human intelligence, how specific genes affect intelligence remains largely unknown. A multi-institution team led by a University of Utah USTAR researcher has found that the brain gene STX1A plays a significant role in the level of intelligence displayed by patients with Williams Syndrome.

23 Apr 2010

COSMOS project launched to investigate link between use of mobile phones and health problems

A new decades-long study launches today to investigate whether there is a link between the use of mobile phones and long-term health problems such as cancer.

23 Apr 2010

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

A new Mayo Clinic study found that physical exercise and computer use may help protect against mild cognitive impairment, a disorder of the brain that affects nerve cells involved in thinking abilities.

23 Apr 2010

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Baxter International Inc. today reported first quarter net income of $525 million, an increase of 2 percent from $516 million reported in the first quarter of 2009. Earnings per diluted share of $0.86 increased 4 percent from $0.83 per diluted share reported in the prior-year period. Baxter's first quarter financial results included a one-time, non-cash special charge of $39 million (or $0.07 per diluted share) related to a change in the tax treatment of post-retirement prescription drug benefits under recent U.S. healthcare reform legislation.

From Baxter International Inc. 22 Apr 2010

Mild Cognitive Impairment Symposium is now 'Symposium on Early Alzheimer's Disease'

This year, the Miami Beach symposium kicked off on a rainy Friday with a new name and a new focus on biomarkers. For seven years, the meeting has been called the Mild Cognitive Impairment Symposium, but that changed this year to the Symposium on Early Alzheimer's Disease. The change comes as a nod to a recent and dramatic shift in how Alzheimer disease is perceived, and what researchers increasingly see as the most promising angle of attack for future therapeutics.

22 Apr 2010

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Ceregene continues enrollment in new Phase 1/2 clinical study of CERE-120 for Parkinson's disease

Researchers find Alzheimer's pathology to originate from Amyloid-Beta oligomers in the brain

FIESTY acronym to improve cognitive function, reduce chances of developing dementia

A first step in the long road to health reform

Aton Pharma acquires the U.S. marketing rights to LODOSYN tablets from BMS

Intellect Neurosciences completes restructuring of balance sheet

Elderlink offers personalized referral lists for senior citizens and their families

Long telomeres in non-demented adults and seniors associated with poorer memory: Researchers

Heritage Club Mountain View to host intense competition and educational event

High nitrate concentrations in drinking water are a potential hazard to human health

World’s largest study on the safety of using mobile phones

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

Research into Planarian worm 'Smed-prep' gene may pave way for regeneration of human organs

People who provide care to family members with dementia experience stress, depression: Researchers

Alzheimer's Association's hosts conference to educate and support NH people with the disease

Study describes relationship between gene expression and intelligence in WS patients

COSMOS project launched to investigate link between use of mobile phones and health problems

Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic

Baxter International's global sales for first-quarter advances by 11% to $3.1 billion

Mild Cognitive Impairment Symposium is now 'Symposium on Early Alzheimer's Disease'

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in